Cyclophosphamide in chronic lymphocytic leukemia first line: final results of Chronic Lymphocytic Leukemia 8 Study


https://doi.org/10.4081/hmr.v3i3.581
Vol. 3 No. 3: 7th Meeting New Insights in Hematology Venice, Italy, 26-29 April 2009
Published: June 12, 2009
Abstract Views: 5563
PDF: 701
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The prognosis of patients with CLL (chronic lymphocytic leukemia) is extremely variable. The overall median survival is about 10 years, but besides patients whose disease has an indolent course and who have a survival no different from that of the general population, there are others who have a rapidly evolving and fatal course.1 Clinical staging (Rai et al. 1975 and Binet et al. 1981) at diagnosis remains the gold standard system for deciding when to treat a patient with CLL.2

Supporting Agencies


Gobbi, M. (2009). Cyclophosphamide in chronic lymphocytic leukemia first line: final results of Chronic Lymphocytic Leukemia 8 Study. Hematology Meeting Reports (formerly Haematologica Reports), 3(3). https://doi.org/10.4081/hmr.v3i3.581
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC